Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N4BP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | MED12 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | SPIN4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | ZNF610 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | NBPF10 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-07 |
mRNA | CTC-273B12.7 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | SOGA3 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | SCGB2B2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |